Keynote Speakers’ Biographies

Dr Damian Conway MB BCh MMed PhD FAChSHM

Dr Damian Conway is a Sexual Health Physician and Conjoint Lecturer at The Kirby Institute, University of New South Wales, where he was awarded his PhD in 2015. He received his medical degree from Queen’s University in Belfast, his Master of Medicine degree from the University of Sydney and is a Fellow of the Australasian Chapter of Sexual Health Medicine.

In 2011, he established and was principal investigator in the Sydney Rapid HIV Test Study which was the first clinical multi-site evaluation of point-of-care HIV testing in Australia. His research interests are the epidemiology, diagnosis and treatment of HIV and sexually transmitted infections, with a focus on the implementation and evaluation of novel approaches to testing in a range of clinical and community settings.



Dr. Devitt is a Consultant Physician at the Chelsea and Westminster Hospital NHS Foundation Trust in London, UK. She graduated from the University of Dublin, Trinity College in 2000. She completed her specialist training in Infectious Diseases and General Internal Medicine in Ireland in 2009. She was awarded her MD in Hepatitis C from University College Dublin.

She has been working at Chelsea and Westminster since 2009 where she has a specific interest in the medical complications of HIV and management of viral hepatitis. She does outpatient clinics at 56 Dean Street Clinic in Central London which is Europe’s busiest Sexual Health clinic with large numbers of new HIV, Hepatitis C and bacterial STI diagnoses annually. Her outpatient work includes HIV and viral hepatitis management along with HIV prevention (PreP) and outreach clinics to high risk patients in the local community including Homeless individuals. Her inpatient work is on a dedicated 19 bed HIV and HIV Oncology ward at the Chelsea and Westminster Hospital.


Dr. Fidelma Fitzpatrick

Dr Fitzpatrick is a Senior Lecturer, Royal College of Surgeons in Ireland and Consultant Microbiologist, Beaumont Hospital, Dublin, Ireland. As the first National clinical lead for the prevention of healthcare-associated infection (HCAI) and antimicrobial resistance (AMR) from 2010-2014, she established the national clinical programme and oversaw the transition of governance of the functions of the SARI (Strategy for the Control of Antimicrobial Resistance in Ireland) national committee to the Royal College of Physicians of Ireland (RCPI) and the HSE.   As clinical lead, Dr. Fitzpatrick coordinated the national HCAI and AMR workplan, led the national public information campaign on antibiotics in conjunction with the ICGP AMR lead and oversaw the establishment of the National AMR Intersectoral Coordinating Committee. She is chair of the National Sepsis Governance Committee and the National C. difficile Guidelines Committee and is a member of the national clinical advisory group of the HCAI and AMR clinical programme.


Professor David Livermore

David Livermore gained his BSc in 1978 and his PhD in 1983. He worked at the London Hospital Medical College from 1980 until 1997 when he joined the Health Protection Agency (now Public Health England), becoming Director of its Antibiotic Resistance Monitoring and Reference Laboratory in 1998. In October 2011 he became Professor of Medical Microbiology at the University of East Anglia but with 30% of this time supplied back to Public Health England as its Lead on Antibiotic Resistance. He has broad interests on the evolution and dissemination of antibiotic resistance and its relationship to antibiotic prescribing.

Prof Livermore sits on the British Society for Antimicrobial Chemotherapy’s working parties on resistance surveillance, multi-resistant pathogens and susceptibility testing and its Antibiotic Action advisory board and is a member of the UK Government’s Antimicrobial Resistance & Healthcare Infections Advisory Committee. He publishes and speaks widely on resistance and has edited for several journals including Journal of Antimicrobial Chemotherapy, Journal of Medical Microbiology and, currently, International Journal of Antimicrobial Agents.


Sanjay Pujari MD

  • B.B.S. and M.D. (internal Medicine), B.J. Medical College Pune
  • Director and Chief Consultant, Institute of Infectious Diseases, Pune
  • Consultant in HIV Medicine and Infectious Diseases, Poona Hospital Research Centre
  • Principal Investigator:
    • Therapeutics, Research, Education in AIDS Treatment (TREATAsia), Pune site
    • Strategic Timing of Antiretroviral treatment (START) study, Pune site
  • Founding and Board Member, HIV Medicine Association of India
  • Temporary Consultant to World Health Organization, 2001
  • Presented and published numerous papers, nationally and internationally (49 pubmed indexed)
  • Faculty at more than 1000 meetings incl the European AIDS Clinical Society Advanced Course (2014), American College of Physicians, India Conference (2014), Advanced Course in HIV Medicine with Royal Free hospital, London (2011,2012).
  • Awards
    • Association of Physicians of India, Kolhapur branch, oration award, 2014
    • Prataprao Pawar Award for work in HIV, Nashik 2012
    • Pune Ki Aasha, 2002
    • Shankarao Kirolaskar award for community service in AIDS, 2001
    • Rotary club of Poona Downtwon, Vocational excellence award, 2001